DeLuca Teresa 4

What Happened

• Teresa DeLuca, a director of LifeStance Health Group, Inc. (LFST), received an award of 17,746 restricted stock units (RSUs) reported as an acquisition on July 2, 2026. The RSUs were granted at $0.00 per unit (typical for equity awards); the filing reports an acquisition of 17,746 RSUs.

Key Details

• Transaction date: 2026-07-02; Form 4 filed: 2026-07-07.
• Transaction type/code: Award/Grant (code A).
• Amount: 17,746 RSUs granted, reported as acquired at $0.00 per unit.
• Footnote: Each RSU represents a contingent right to receive one share of common stock upon vesting.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: The Form 4 was filed five days after the reported transaction; Form 4s are typically due within two business days, so this may indicate a late filing.

Context

• RSUs are equity awards that convert to actual shares only when vesting conditions are met; they are not an open-market purchase or sale and do not by themselves signal immediate buying or selling. No immediate sale or option exercise was reported in this filing.